Navigation Links
Xoft Recognized With R&D 100 Award
Date:7/24/2008

R&D Magazine Selects Axxent(R) Miniature Brachytherapy X-ray Source as One of the 100 Most Technologically Significant Products of the Past Year

SUNNYVALE, Calif., July 24 /PRNewswire/ -- Xoft, Inc. today announced that the Axxent(R) High Dose Rate (HDR) X-ray Source has been selected to receive an R&D 100 Award from R&D Magazine as one of the year's most technologically significant products. Established by the editors of R&D Magazine in 1963, the R&D 100 Awards are designed to recognize significant technological achievements and products that leapfrog current technology and that provide simple, elegant solutions to complex or long-standing technical or practical problems.

Over the past 45 years, the R&D 100 Awards have recognized winning products with such household names as the flashcube (1965), the automated teller machine (1973), the fax machine (1975), the liquid crystal display (1980), the Kodak Photo CD (1991), the Nicoderm antismoking patch (1992), Taxol anticancer drug (1993), and HDTV (1998).

"The Axxent miniature X-ray source is a fundamentally new way to deliver therapeutic radiation. Previously, there has been external beam radiation, generally delivered by a linear accelerator, or brachytherapy, a radioactive isotope delivering radiation internal to the body," said Paul Lovoi PhD, CTO and co-founder of Xoft. "The Axxent source can deliver internal or external radiation and, because of the lower energy, can deliver this radiation in any minimally-shielded setting. Until the Xoft miniature X-ray source, there has been no new modality of radiation treatment in over 40 years. The Xoft Axxent X-ray source is the enabling technology for many generations of increasingly more sophisticated, accurate, and accessible radiation treatment systems."

The Axxent(R) HDR X-ray source is a miniature disposable X-ray tube, 2.25 mm in diameter, that can be inserted into the body to deliver a 50 kVp therapeutic dose of radiation for cancer treatment. In comparison, the next smallest medical X-ray source currently in use is more than 10 times larger. The source is part of the Axxent Electronic Brachytherapy System which is FDA cleared for use in the radiation treatment of cancers or other conditions. Specific applicators are cleared for treatment of early stage breast cancer and for endometrial and rectal cancers.

As a platform technology, the Axxent System is designed to deliver non-radioactive therapy directly to cancer sites with minimal radiation exposure to surrounding healthy tissue. Because of its unique characteristics, radiation from the Axxent HDR X-ray Source can be easily shielded, allowing medical personnel to be present during treatment delivery, minimizing patient anxiety.

"Eliminating the need for the heavily-shielded vaults required by existing radiation therapy technologies, such as radioactive isotopes and linear accelerators, will allow the therapy to move to the patient rather than forcing the patient to come to specialty treatment centers. This will make the best treatment available annually to tens of thousands of cancer patients worldwide that otherwise would not receive it. This is especially important for patients that may not have access to specialized vaults because of the cost of travel and lodging plus the impact of being absent from jobs and families during treatment," said Tom Rusch, PhD, VP of Technical Outreach and Xoft co-founder.

"Known as one of the most prestigious honors in the field of research and development, the R&D 100 Award is a mark of excellence known to industry, government, and academia validating that the product is one of the most innovative ideas of the year," said Michael Klein, president and CEO of Xoft. "We are extremely proud of our R&D team and their efforts to invent and bring to market a paradigm shifting technology in the treatment of cancer. Not only does the Axxent System have the potential to dramatically improve access to an easier and more convenient form of treatment, it also supports the federal government directive to develop viable substitutes for radioactive isotopes which carry environmental and national security concerns."

To learn more about the R&D 100 Awards, visit http://www.RDmag.com

About Xoft, Inc.

Founded in 1998, Xoft develops leading-edge technologies for the practice of radiation oncology through Electronic Brachytherapy, which utilizes proprietary miniaturized X-ray tube technology. The Axxent(R) Electronic Brachytherapy System, Xoft's first treatment system, is currently being used in Accelerated Partial Breast Irradiation (APBI) for the treatment of early-stage breast cancer and in the treatment of endometrial cancer. For more information, visit http://www.xoftinc.com

Axxent is a registered trademark of Xoft, Inc.


'/>"/>
SOURCE Xoft, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
2. Cadient Group Recognized with Five Awards at 14th Annual Communicator Awards
3. Texas Oncology-Baylor Sammons Cancer Center Recognized for Highest Commitment to Clinical Research at ASCO
4. Sigma-Aldrich Recognized by BioInformatics, LLC as Having the Most Useful and Easiest to Use Online and Print Catalogs
5. ARIUS recognized for entrepreneurial excellence
6. NYU chemist Seeman recognized for founding, establishing the field of structural DNA nanotechnology
7. Halogen Receives High Ratings from Bersin & Associates - Company recognized as a market leader, and receives praise for outstanding customer satisfaction
8. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
9. International Human Rights Day Recognized by Terasem Movement, Inc.s Third Annual Colloquium on the Law of Transbeman Persons
10. MedImmune Recognized by Local Volunteer Organization for Its Employees Exceptional Commitment to Community Service within Montgomery County
11. Netsmart Technologies Customer in Pennsylvania Recognized for Achieving Data Benchmarking Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... RPS ... clinical study that demonstrates the accuracy of the FebriDx® test, a commercially-ready, ... acute bacterial and viral respiratory tract infections by testing the body’s immune ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology:
(Date:5/23/2017)... first robotic gym for the rehabilitation and functional motor sense evaluation of ... Italy . The first 30 robots will be available from June ... . The technology was developed and patented at the IIT laboratories and ... thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:5/6/2017)... May 5, 2017 RAM Group ... a new breakthrough in biometric authentication based on ... mechanical properties to perform biometric authentication. These new sensors ... material created by Ram Group and its partners. This ... transportation, supply chains and security. Ram Group is ...
(Date:4/18/2017)... Calif. , April 18, 2017  Socionext Inc., a global ... of a media edge server, the M820, which features the company,s ... recognition software provided by Tera Probe, Inc., will be showcased during ... at the NAB show at the Las Vegas ... ...
Breaking Biology News(10 mins):